Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Femoral port placement - report of two cases.

Harish K, Madhu YC.

Indian J Surg Oncol. 2011 Mar;2(1):31-3. doi: 10.1007/s13193-011-0071-9. Epub 2011 May 24. No abstract available.

2.

Percutaneous femoral catheter placement for long-term chemotherapy infusions: preliminary technical results.

Tajima T, Yoshimitsu K, Kuroiwa T, Ishibashi T, Irie H, Aibe H, Shinozaki K, Nishie A, Yabuuchi H, Honda H.

AJR Am J Roentgenol. 2005 Mar;184(3):906-14.

PMID:
15728616
3.

Optimizing robotic renal surgery: the lateral camera port placement technique and current results.

Badani KK, Muhletaler F, Fumo M, Kaul S, Peabody JO, Bhandari M, Menon M.

J Endourol. 2008 Mar;22(3):507-10. doi: 10.1089/end.2007.0228.

PMID:
18355144
4.

Femoral-to-port through-and-through wire access to reestablish subcutaneous port function.

Sobolevsky S, Sheiman RG, Faintuch S, Perry L.

AJR Am J Roentgenol. 2007 Apr;188(4):1047-9.

PMID:
17377044
5.

Totally implantable venous access port via the femoral vein in a femoral port position with CT-venography.

Kato K, Iwasaki Y, Onodera K, Higuchi M, Kato K, Kato Y, Matsuda M, Endo S, Kobashi Y, Taniguchi M.

J Surg Oncol. 2016 Dec;114(8):1024-1028. doi: 10.1002/jso.24441. Epub 2016 Sep 22.

PMID:
27658579
6.

[First experiences with ultrasound guided subclavian vein port placement in ENT].

Sutor T, Schmidt H, Stasche N.

Laryngorhinootologie. 2012 Jan;91(1):28-31. doi: 10.1055/s-0031-1291329. Epub 2012 Jan 9. German.

PMID:
22231965
7.

Liver regional continuous chemotherapy: use of femoral or subclavian artery for percutaneous implantation of catheter-port systems.

Zhu AL, Liu LX, Piao DX, Lin YX, Zhao JP, Jiang HC.

World J Gastroenterol. 2004 Jun 1;10(11):1659-62.

8.

Wound dehiscence or failure to heal following venous access port placement in patients receiving bevacizumab therapy.

Zawacki WJ, Walker TG, DeVasher E, Halpern EF, Waltman AC, Wicky ST, Ryan DP, Kalva SP.

J Vasc Interv Radiol. 2009 May;20(5):624-7; quiz 571. doi: 10.1016/j.jvir.2009.01.022. Epub 2009 Mar 27.

PMID:
19328717
9.

Human performance in the task of port placement for biosensor use.

King BW, Reisner LA, Ellis RD, Klein MD, Auner GW, Pandya AK.

Int J Med Robot. 2010 Jun;6(2):150-9. doi: 10.1002/rcs.300.

10.

Clinical predictors of port infections within the first 30 days of placement.

Bamba R, Lorenz JM, Lale AJ, Funaki BS, Zangan SM.

J Vasc Interv Radiol. 2014 Mar;25(3):419-23. doi: 10.1016/j.jvir.2013.11.038.

PMID:
24581465
11.

Optimized port placement for in vivo biosensors.

King BW, Reisner LA, Ellis RD, Klein MD, Auner GW, Pandya AK.

Int J Med Robot. 2009 Sep;5(3):267-75. doi: 10.1002/rcs.257.

PMID:
19402052
12.

Laparoscopic intraperitoneal port placement for optimally cytoreduced advanced ovarian cancer.

Janco JM, Hacker MR, Konstantinopoulos PA, Cannistra SA, Awtrey CS.

J Minim Invasive Gynecol. 2011 Sep-Oct;18(5):629-33. doi: 10.1016/j.jmig.2011.06.005. Epub 2011 Jul 30.

PMID:
21803662
13.

Rupture of totally implantable central venous access devices (Intraports) in patients with cancer: report of four cases.

Filippou DK, Tsikkinis C, Filippou GK, Nissiotis A, Rizos S.

World J Surg Oncol. 2004 Oct 19;2:36.

14.

A medical school experience with three port laparoscopic cholecystectomy with a new modification in technique.

Chalkoo M, Ahangar S, Patloo AM, Matoo AR, Baqal FS, Iqbal S.

Int J Surg. 2013;11(1):37-40. doi: 10.1016/j.ijsu.2012.11.005. Epub 2012 Nov 16.

15.

Hepatic arterial infusion chemotherapy by the fixed-catheter-tip method: retrospective comparison of percutaneous left subclavian and femoral port-catheter system implantation.

Matsumoto T, Yamagami T, Yoshimatsu R, Morishita H, Kitamura N, Sato O, Hasebe T.

AJR Am J Roentgenol. 2014 Jan;202(1):211-5. doi: 10.2214/AJR.12.10502.

PMID:
24370146
16.

Port-A-Cath placement without the aid of fluoroscopy or localizing devices: a community hospital series.

LaBella G, Kerlakian G, Muck P, Chung D, Vaughan A, Ritchison A.

Cancer J. 2005 Mar-Apr;11(2):157-9.

PMID:
15969992
17.

Outpatient placement of subcutaneous venous access ports reduces the rate of infection and dehiscence compared with inpatient placement.

Pandey N, Chittams JL, Trerotola SO.

J Vasc Interv Radiol. 2013 Jun;24(6):849-54. doi: 10.1016/j.jvir.2013.02.012. Epub 2013 Apr 10.

PMID:
23582442
18.

Optimal port placement during laparoscopic radical prostatectomy.

Chawla A, Qureshi A, Alamri A, Matsumoto ED.

Can J Urol. 2012 Feb;19(1):6142-6.

PMID:
22316520
19.

Hepatic arterial port systems for treatment of liver metastases: factors affecting patency and adverse events.

Ricke J, Hildebrandt B, Miersch A, Nicolaou A, Warschewske G, Teichgräber U, Lopez Hänninen E, Riess H, Felix R.

J Vasc Interv Radiol. 2004 Aug;15(8):825-33.

PMID:
15297586
20.

Arterial port catheter system placement using a translumbar aortic route.

Clark TW, Bilo JM, Beecroft JR.

Invest Radiol. 2002 Jan;37(1):7-12.

PMID:
11753148

Supplemental Content

Support Center